European Journal of Radiology
Volume 53, Issue 3 , Pages 506-513 , March 2005

In vivo and ex vivo proton MR spectroscopy of primary and secondary melanoma

  • Roger M. Bourne

      Affiliations

    • Institute for Magnetic Resonance Research, Department of Magnetic Resonance in Medicine, University of Sydney, Block 3, Level 3, Royal North Shore Hospital, St. Leonards, NSW 2065, Australia
    • ,
  • Peter Stanwell

      Affiliations

    • Institute for Magnetic Resonance Research, Department of Magnetic Resonance in Medicine, University of Sydney, Block 3, Level 3, Royal North Shore Hospital, St. Leonards, NSW 2065, Australia
    • ,
  • Jonathan R. Stretch

      Affiliations

    • Sydney Melanoma Unit and Melanoma and Skin Cancer Research Institute, Royal Prince Alfred Hospital, University of Sydney, Camperdown, NSW 2050, Australia
    • ,
  • Richard A. Scolyer

      Affiliations

    • Sydney Melanoma Unit and Melanoma and Skin Cancer Research Institute, Royal Prince Alfred Hospital, University of Sydney, Camperdown, NSW 2050, Australia
    • Department of Anatomical Pathology, Royal Prince Alfred Hospital, Camperdown, NSW 2050, Australia
    • ,
  • John F. Thompson

      Affiliations

    • Sydney Melanoma Unit and Melanoma and Skin Cancer Research Institute, Royal Prince Alfred Hospital, University of Sydney, Camperdown, NSW 2050, Australia
    • ,
  • Carolyn E. Mountford

      Affiliations

    • Institute for Magnetic Resonance Research, Department of Magnetic Resonance in Medicine, University of Sydney, Block 3, Level 3, Royal North Shore Hospital, St. Leonards, NSW 2065, Australia
    • ,
  • Cynthia L. Lean

      Affiliations

    • Institute for Magnetic Resonance Research, Department of Magnetic Resonance in Medicine, University of Sydney, Block 3, Level 3, Royal North Shore Hospital, St. Leonards, NSW 2065, Australia
    • Corresponding Author InformationCorresponding author. Tel.: +61-2-9926-6073; fax: +61-2-9926-6549.

Received 4 September 2003 ,Revised 29 March 2004 ,Accepted 31 March 2004.

References 

  1. Serraino D, Fratino L, Gianni W, et al.  Epidemiological aspects of cutaneous malignant melanoma (review). Oncol. Reports. 1998;5(4):905–909
  2. Lean C, Bourne R, Thompson J, et al. Rapid detection of metastatic melanoma in lymph nodes using proton magnetic resonance spectroscopy of fine needle aspiration biopsy specimens. Melanoma Res. 2003;13:259–61.
  3. Querleux B, Jolivet O, Bittoun J. In vivo proton magnetic resonance spectroscopy in human skin. Curr. Probl. Dermatol. 1998;26:12–19
  4. Kim YH, Orenberg EK, Faull KF, Wade-Jardetzky NG, Jardetzky O. 1H NMR spectroscopy: an approach to evaluation of diseased skin in vivo. J. Invest. Dermatol. 1989;92(2):210–216
  5. Davidorf F, Chambers R, Gresak P. False-positive magnetic-resonance-imaging of a metastatic carcinoma simulating a malignant-melanoma. Ann. Ophthalmol. 1992;24:391–394
  6. Bloom P, Ferris J, Laidlaw D, Goddard P. Magnetic-resonance-imaging-diverse appearances of uveal malignant melanomas. Arch. Ophthalmol. 1992;110:1105–1111
  7. Ferris J, Bloom P, Goddard P, Collins C. Quantification of melanin and iron content in uveal malignant melanomas and correlation with magnetic-resonance image. Br. J. Ophthalmol. 1993;77:297–301
  8. Liu KR, Peyman GA, Mafee MF, Yu DY. False positive magnetic-resonance imaging of a choroidal nevus simulating choroidal melanoma. Int. Ophthalmol. 1989;13:265–268
  9. Lemke AJ, Hosten N, Wiegel T, et al.  Intraocular metastases: differential diagnosis from uveal melanomas with high-resolution MRI using a surface coil. Eur. Radiol. 2001;11(12):2593–2601
  10. Takahashi M, Kohda H. Diagnostic utility of magnetic resonance imaging in malignant melanoma. J. Am. Acad. Dermatol. 1992;27(1):51–54
  11. Hawnaur JM, Dobson MJ, Zhu XP, Watson Y. Skin: MR imaging findings at middle field strength. Radiology. 1996;201(3):868–872
  12. Ak I, Stokkel MP, Bergman W, Pauwels EK. Cutaneous malignant melanoma: clinical aspects, imaging modalities and treatment. Eur. J. Nucl. Med. 2000;27(4):447–458
  13. Lean CL, Somorjai RL, Smith ICP, Russell PR, Mountford CE. In: Webb G, editor. Accurate diagnosis and prognosis of human cancers by proton MRS and a three stage classification strategy. Ann Reports NMR Spectrosc: Academic Press; 2002. p. 71–111.
  14. Danielsen ER, Ross BD. Magnetic resonance spectroscopy: diagnosis of neurological diseases. New York: Marcel Dekker; 1999.
  15. Kurhanewicz J, Vigneron DB, Males RG, Swanson MG, Yu KK, Hricak H. The prostate: MR imaging and spectroscopy. Present and future. Radiol. Clin. North Am. 2000;38(1):115–138 viii–ix
  16. Bottomley PA. Spatial localization in NMR spectroscopy in vivo. Ann. N.Y. Acad. Sci. 1987;508:333–348
  17. Tran T-KC, Vigneron DB, Sailasuta N, et al. Improving clinical MRSI with very selective saturation pulses to reduce chemical shift errors and conform press selection. In: Proceedings of the Eighth Annual Meeting of the ISMRM, Denver, USA; 2000. p. 366.
  18. Tran T-KC, Vigneron DB, Sailasuta N, et al.  Very selective suppression pulses for clinical MRSI studies of brain and prostate cancer. Magn. Reson. Med. 2000;43(1):23–33
  19. Haase A, Frahm J, Hanicke W, Matthaei D. 1H NMR chemical shift selective (chess) imaging. Phys. Med. Biol. 1985;30(4):341–344
  20. Bourne R, Dzendrowskyj T, Mountford C. Leakage of metabolites from tissue biopsies can result in large errors in quantitation by MRS. NMR Biomed. 2003;16:1–6
  21. Braun S, Kalinowski H-O, Berger S. 150 and more basic NMR experiments: a practical course, 2nd ed. Weinheim: Wiley–VCH; 1998.
  22. Zemtsov A, Lorig R, Ng Tc Xue M, et al.  Magnetic-resonance-imaging of cutaneous neoplasms-clinicopathological correlation. J. Dermatol. Surg. Oncol. 1991;17:416–422
  23. Isiklar I, Leeds N, Fuller G, Kumar A. Intracranial metastatic melanoma-correlation between MR-imaging characteristics and melanin content. Am. J. Roentgenol. 1995;165:1503–1512
  24. Morvan D, Demidem A, Papon J, De Latour M, Madelmont JC. Melanoma tumors acquire a new phospholipid metabolism phenotype under cystemustine as revealed by high-resolution magic angle spinning proton nuclear magnetic resonance spectroscopy of intact tumor samples. Cancer Res. 2002;62(6):1890–1897
  25. Dobrota D, Pec J, Pec M, et al.  Study of malignant melanoma using 1H-nuclear magnetic resonance spectroscopy. Bratisl. Lek. Listy. 1995;96(3):134–136
  26. El-Sayed S, Bezabeh T, Odlum O, et al.  An ex vivo study exploring the diagnostic potential of 1H magnetic resonance spectroscopy in squamous cell carcinoma of the head and neck region. Head Neck. 2002;24(8):766–772
  27. Crotty K, Scolyer R, Li L, Palmer A, Wang L, McCarthy S. Spitz naevus versus spitzoid melanoma: when and how can they be distinguished?. Pathology (Phila). 2002;34:6–12

PII: S0720-048X(04)00111-1

doi: 10.1016/j.ejrad.2004.03.016

European Journal of Radiology
Volume 53, Issue 3 , Pages 506-513 , March 2005

Article Tools

* Image Usage & Resolution